In vitro and in vivo evaluation of isatin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections

Antiviral Research

Volumn 71, Issue 1, 2006, Pages 24-30

  Quenelle, Debra C ^a   Keith, Kathy A ^a   Kern, Earl R ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Antiviral; IBT; Marboran; Orthopoxvirus

Indexed keywords

CIDOFOVIR; ISATIN 3 THIOSEMICARBAZONE; METISAZONE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; COWPOX; COWPOX VIRUS; EXPERIMENTAL INFECTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; INOCULATION; KIDNEY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFECTION; SMALLPOX; SPLEEN; THERAPY DELAY; THERAPY EFFECT; TREATMENT RESPONSE; VACCINIA; VACCINIA VIRUS; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; COWPOX VIRUS; FEMALE; HYDRAZONES; INDOLES; METHISAZONE; MICE; MICE, INBRED BALB C; MICE, INBRED HRS; POXVIRIDAE INFECTIONS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; VACCINIA VIRUS; VIRUS REPLICATION;

COWPOX VIRUS; ORTHOPOXVIRUS; VACCINIA VIRUS; VARIOLA; VARIOLA VIRUS;

EID: 33745211022     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.02.010     Document Type: Article

References (29)

1. Baker R.O., Bray M., and Huggins J.W. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 57 (2003) 13-23
2. Bauer D.J. The antiviral and synergic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice. Br. J. Exp. Pathol. 36 (1955) 105-114
3. Bauer D.J., and Sadler P.W. New antiviral chemotherapeutic agent active against smallpox infection. Lancet 1 (1960) 1110-1111
4. Bauer D.J. Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone). Ann. NY Acad. Sci. 130 (1965) 110-117
5. Bauer D.J. Monocyclic thiosemicarbazones as antiviral agents. Ann. NY Acad. Sci. 130 (1965) 105-109
6. Bauer D.J. Chemoprophylaxis of smallpox and treatment of vaccinia gangrenosa with 1-methylisatin 3-thiosemicarbazone. Antimicrob. Agents Chemother. 5 (1965) 544-547
7. Bauer D.J., Dumbell K.R., Fox-Hulme P., and Sadler P.W. The chemotherapy of variola major infection. Bull. World Health Organ 26 (1962) 727-732
8. Bauer D.J., St. Vincent L., Kempe C.H., Young P.A., and Downie A.W. Prophylaxis of smallpox with methisazone. Am. J. Epidemiol. 90 (1969) 130-145
9. Bauer D.J., St. Vincent L., Kempe C.H., and Downie A.W. Prophylactic treatment of smallpox contacts with n-methylisatin β-thiosemicarbazone. Lancet ii (1963) 494-496
10. Borysiewicz J., and Witalinski W. Effect of N,N′-bis (methylisatin-beta-thiosemicarbazone)-2-methylpiperazine on vaccinia virus replication in vitro and in vivo. Arch. Virol. 62 (1979) 83-86
11. Boyle J.J., Haff R.F., and Stewart R.C. Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice. Antimicrob. Agents Chemother. 6 (1966) 536-539
12. De Clercq E. Cidofovir in the treatment of poxvirus infections. Antiviral Res. 55 (2002) 1-13
13. Domagk G., Behnisch R., Mietsch F., and Schmidt H. Über eine neue, gegen Tuberkelbazillen in vitro wirksame Verbindungsklasse. Naturwissenschaften 10 (1946) 315
14. Heiner G.G., Fatima N., Russell P.K., Haase A.T., Ahmad N., Mohammed N., Thomas D.B., Mack T.M., Khan M.M., Knatterud G.L., Anthony R.L., and McCrumb Jr. F.R. Field trials of methisazone as a prophylactic agent against smallpox. Am. J. Epidemiol. 94 (1971) 435-449
15. Keith K.A., Hitchcock M.J., Lee W.A., Holý A., and Kern E.R. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication. Antimicrob. Agents Chemother. 47 (2003) 2193-2198
16. Magee W.C., Hostetler K.Y., and Evans D.H. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicrob. Agents Chemother. 49 (2005) 3153-3162
17. Neyts J., and De Clercq E. Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives. Antiviral Res. 57 (2003) 25-33
18. Pirrung M.C., Pansare S.V., Sarma K.D., Keith K.A., and Kern E.R. Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-pox agents. J. Med. Chem. 48 (2005) 3045-3050
19. Prichard M.N., and Kern E.R. Orthopoxvirus targets for the development of antiviral therapies. Curr. Drug Targets Infect. Disord. 5 (2005) 17-28
20. Prins C., Cresawn S.G., and Condit R.C. An Isatin-β-thiosemicarbazone-resistant vaccinia virus containing a mutation in the second largest subunit of the viral RNA polymerase is defective in transcription elongation. J. Biol. Chem. 279 (2004) 44858-44871
21. Quenelle D.C., Collins D.J., and Kern E.R. Efficacy of multiple-or single-dose cidofovir against vaccinia and cowpox infections in mice. Antimicrob. Agents Chemother. 47 (2003) 3275-3280
22. Quenelle D.C., Collins D.J., and Kern E.R. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir. Antiviral Res. 63 (2004) 33-40
23. Quenelle D.C., Collins D.J., Wan W.B., Beadle J.R., Hostetler K.Y., and Kern E.R. Oral treatment of cowpox and vaccinia infections in mice with ether lipid esters of cidofovir. Antimicrob. Agents Chemother. 48 (2004) 404-412
24. Rao A.R., McFadzean J.A., and Squires S. The laboratory and clinical assessment of an isothiazole thiosemicarbazone (M&B 7714) against pox viruses. Ann. NY Acad. Sci. 130 (1965) 118-127
25. Smee D.F., Bailey K.W., Wong M.H., Wandersee M.K., and Sidwell R.W. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. J. Infect. Dis. 190 (2004) 1132-1139
26. Smee D.F., and Sidwell R.W. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 57 (2003) 41-52
27. Turner W., Bauer D.J., and Nimmo-Smith R.H. Eczema vaccinatum treated with N-methylisatin beta-thiosemicarbazone. Br. Med. J. i (1962) 1317-1319
28. Walter M., Kolarz B., and Zgorniak-Nowosielska I. Evaluation of ectodermal lesions in intravenous vaccinia infected mice as a method to investigate the antiviral activity of isatin beta-thiosemicarbazone derivative (TSK VI compound). Arch. Immunol. Ther. Exp. 29 (1981) 187-194
29. Zgornaik-Nowosielska I., Gatkiewicz A., Veckenstedt A., and Beladi I. Effect of N,N′-bis(methylisatin-beta-thiosemicarbazone)-2-methylpiperazine against virus-induced encephalitis in mice. Acta. Virol. 24 (1980) 439-444